Rafael logo
Rafael
RFL | NYSE
Chart Builder DCF Calculator
$0.97
-$0.10 (-9.35%)
At close: Nov 16, 2026, 4:00 PM ET
$0.97
$0.00 (+0.01%)
After-hours: Nov 16, 2026, 4:00 PM ET

Rafael Company Profile

Company profile explained

Company Profile

Rafael Holdings, Inc. holds strategic investments in both early-stage and clinical pharmaceutical companies, alongside a portfolio of commercial real estate assets situated in the United States and Israel. The company's business activities are structured into two primary divisions: Pharmaceuticals and Real Estate. Its Real Estate segment manages and leases a commercial office complex, which features an integrated 800-space public parking facility. The Pharmaceutical division, conversely, focuses on developing and bringing to market therapies designed to capitalize on the metabolic distinctions between healthy cells and malignant ones. The firm's flagship drug candidate is CPI-613 (devimistat), currently undergoing evaluation in numerous clinical trials, including two pivotal Phase III registrational studies for the treatment of advanced pancreatic cancer and relapsed/refractory acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.

Key Executives

Name Position
Howard S. Jonas Chief Executive Officer, President, Founder & Executive Chairman
David A. Polinsky Chief Financial Officer
Joshua Fine Chief Operating Officer
Joyce J. Mason Corporate Secretary

Latest SEC Filings

Date Type Title
Oct 29, 2026 10-K Annual Report
Oct 29, 2026 8-K Current Report
Oct 27, 2026 4 Filing
Sep 30, 2026 8-K Current Report
Sep 23, 2026 4 Filing
Jul 31, 2026 4 Filing
Jul 08, 2026 8-K Current Report
Jun 23, 2026 4 Filing
Jun 16, 2026 4 Filing
Jun 11, 2026 10-Q Quarterly Report
View All SEC Filings ➞
Rafael
Rafael logo
Country United States
IPO Date Mar 27, 2018
Industry Real Estate - Services
Sector Real Estate
Employees 21
CEO Howard S. Jonas

Contact Details

520 Broad Street Newark, New Jersey 07102 United States

Stock Details

Ticker Symbol RFL
Exchange NYSE
Fiscal Year August - July
Reporting Currency USD
CIK Code 0001713863
CUSIP Number 75062E106
ISIN Number US75062E1064
SIC Code

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.